2 results
Approved WMOWill not start
The primary aim of this study is to investigate if these innovative surgical solutions are effective in maintaining curve reduction without repeat lengthening procedures and complications. Secondary aims are to investigate growth of the instrumented…
Approved WMORecruiting
Phase 1: • To determine the MTD/RP2D regimen of brigatinib monotherapy when administered in pediatric and AYA patients with ALK+ ALCL or ALK+ solid tumors, including ALK+ IMT.• To characterize the PK of brigatinib administered as monotherapy in…